Bhargava V - Search Results

1

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment.

Cantalloube C, Bhargava V, Sultan E, Vacheron F, Batista I, Montay G. Cantalloube C, et al. Among authors: bhargava v. Int J Antimicrob Agents. 2003 Aug;22(2):112-21. doi: 10.1016/s0924-8579(03)00128-6. Int J Antimicrob Agents. 2003. PMID: 12927950 Clinical Trial.

2

Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.

Shi J, Montay G, Chapel S, Hardy P, Barrett JS, Sack M, Marbury T, Swan SK, Vargas R, Leclerc V, Leroy B, Bhargava VO. Shi J, et al. Among authors: bhargava vo. J Clin Pharmacol. 2004 Mar;44(3):234-44. doi: 10.1177/0091270003262952. J Clin Pharmacol. 2004. PMID: 14973302 Clinical Trial.

3

Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.

Shi J, Montay G, Bhargava VO. Shi J, et al. Clin Pharmacokinet. 2005;44(9):915-34. doi: 10.2165/00003088-200544090-00003. Clin Pharmacokinet. 2005. PMID: 16122280 Review.

4

Lack of effect of food on the bioavailability of a new ketolide antibacterial, telithromycin.

Bhargava V, Lenfant B, Perret C, Pascual MH, Sultan E, Montay G. Bhargava V, et al. Scand J Infect Dis. 2002;34(11):823-6. doi: 10.1080/0036554021000026958. Scand J Infect Dis. 2002. PMID: 12578152 Clinical Trial.

5

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.

Shi J, Chapel S, Montay G, Hardy P, Barrett JS, Sica D, Swan SK, Noveck R, Leroy B, Bhargava VO. Shi J, et al. Among authors: bhargava vo. Int J Clin Pharmacol Ther. 2005 Mar;43(3):123-33. doi: 10.5414/cpp43123. Int J Clin Pharmacol Ther. 2005. PMID: 15792396 Clinical Trial.

6

Effects of itraconazole or grapefruit juice on the pharmacokinetics of telithromycin.

Shi J, Montay G, Leroy B, Bhargava VO. Shi J, et al. Pharmacotherapy. 2005 Jan;25(1):42-51. doi: 10.1592/phco.25.1.42.55621. Pharmacotherapy. 2005. PMID: 15767219 Clinical Trial.

7

Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens.

Lodise TP, Preston S, Bhargava V, Bryskier A, Nusrat R, Chapel S, Rangaraju M, Drusano GL. Lodise TP, et al. Among authors: bhargava v. Diagn Microbiol Infect Dis. 2005 May;52(1):45-52. doi: 10.1016/j.diagmicrobio.2004.12.005. Diagn Microbiol Infect Dis. 2005. PMID: 15878442 Clinical Trial.

8

Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers.

Bhargava VO, Shah AK, Weir SJ, Nordbrock EE, Giesing DH. Bhargava VO, et al. J Clin Pharmacol. 1993 May;33(5):439-43. doi: 10.1002/j.1552-4604.1993.tb04684.x. J Clin Pharmacol. 1993. PMID: 8331200 Clinical Trial.

9

Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis.

Shi J, Kovacs SJ, Wang Y, Ludden TM, Bhargava VO. Shi J, et al. J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):419-39. doi: 10.1007/s10928-005-0049-8. J Pharmacokinet Pharmacodyn. 2005. PMID: 16284916

10

Pharmacokinetics of clentiazem after intravenous and oral administration in healthy subjects.

Shah AK, Bhargava VO, Weir SJ, Giesing DH. Shah AK, et al. Among authors: bhargava vo. J Clin Pharmacol. 1993 Apr;33(4):354-9. doi: 10.1002/j.1552-4604.1993.tb04669.x. J Clin Pharmacol. 1993. PMID: 8473551 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters